The Bangko Sentral ng Pilipinas (BSP) on Friday reported net foreign investments of USD283.69 million exiting the Philippines In January 2025. This was a significant improvement compared to the previous month's outflows of USD487.37 million. The decrease, amounting to USD203.68 million or 41.8 percent, points to a recovery in market sentiment despite ongoing global economic pressures.
The Philippines’ posted a substantial trade deficit of USD5.09 billion in January, widening from the USD4.36 billion trade gap in the same month last year, as export growth failed to keep pace with the rise in imports. This wider trade deficit highlights the country’s persistent struggle to meet its domestic needs through local production and its inability to identify new export drivers to strengthen its economic position.
ABS-CBN Corp. has sold a significant portion of its Quezon City property to Ayala Land Inc., one of the country’s largest property developers, for P6.24 billion.
The Energy Regulatory Commission (ERC) has deferred the approval of capital expenditure projects proposed by the National Grid Corporation of the Philippines (NGCP) totaling P20.32 billion.
Agriculture Secretary Francisco Tiu Laurel Jr. on Monday directed the Bureau of Plant Industry (BPI) to conduct an urgent inspection of onion cold storage facilities across the country.
Leading Philippine non-life insurance provider PhilFirst has partnered with global InsurTech firm ProTech to roll out next-generation integrated insurance services across the country.
The country's two biggest revenue agencies are stepping up efforts to make exporting faster and less costly, with the Bureau of Customs (BOC) and the Bureau of Internal Revenue (BIR) rolling out reforms aimed at cutting red tape, expanding digital services and improving the ease of doing business.
SmarTrade is widening its social impact efforts by investing in education and sports programs, reflecting a growing trend among financial services firms to strengthen community engagement while nurturing the next generation.
For decades, lowering stubborn "bad" cholesterol often meant swallowing statins or rolling up a sleeve for regular injections. Now, there's a new option that fits in the palm of your hand.